Federation des caisses Desjardins du Quebec’s Windtree Therapeutics WINT Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio WINT Stock Details WINT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Hold	0	–	-$190	–	2465
2023 Q3	–	Sell	-1	Closed	-$1.11K	–	2276
2023 Q2	$1.25K	Hold	1	–	–	﹤0.01%	2115
2023 Q1	$4.99K	Hold	1	–	–	﹤0.01%	1911
2022 Q4	$8.5K	Buy	+1	New	+$8.89K	﹤0.01%	1914
2022 Q3	–	Hold	0	–	–	–	2186
2022 Q2	–	Hold	0	–	–	–	2403
2022 Q1	–	Hold	0	–	–	–	2339
2021 Q4	–	Hold	0	–	–	–	2363
2020 Q3	–	Hold	0	–	-$7	–	2242
2020 Q2	–	Hold	0	–	–	–	2101

Other funds holding WINT

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's WINT Position: Q4 2023 in Review

Federation des caisses Desjardins du Quebec held its Windtree Therapeutics (WINT) position steady in Q4 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2465.

Federation des caisses Desjardins du Quebec first reported a position in WINT in Q4 2022 and has held it in 3 quarters since. The position peaked at $8.5K in Q4 2022. 6 funds tracked by Wall St. Rank hold WINT as of Q4 2023.

Federation des caisses Desjardins du Quebec held 0 shares of Windtree Therapeutics worth $0 as of Q4 2023.
Federation des caisses Desjardins du Quebec left its Windtree Therapeutics share count unchanged in Q4 2023.
Windtree Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q4 2023, its #2465 holding.
Federation des caisses Desjardins du Quebec first reported a position in Windtree Therapeutics in Q4 2022 and has held it in 3 quarters since.
Federation des caisses Desjardins du Quebec's Windtree Therapeutics position peaked at $8.5K in Q4 2022.
6 funds tracked by Wall St. Rank held Windtree Therapeutics as of Q4 2023.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2023, filed 15 Aug 2024.